is an oral, first-in-class pan-FLT3/pan-BTK inhibitor that is being studied for use in different hematologic malignancies.
| SparkCures ID | 520 |
|---|---|
| Generic Name | Luxeptinib |
| Additional Names | CG-806 |
| Treatment Classifications |
|
There are no resources, links or videos to display for this treatment.